Pfizer Places Order For Shanxi Xintianyuan’s Pharmaceutical Intermediates
This article was originally published in PharmAsia News
Executive Summary
Pfizer has officially placed a total order of RMB 100 million to purchase 500 tonnes of PCP per year from Shanxi Xintianyuan Pharm. & Chem. Shanxi Xintianyuan is one of Shanxi province's largest pharmaceutical intermediate manufacturers. The firm's main product, HO-EPCP, has secured a share of 30 percent, 40 percent and 85 percent in global, Asia and domestic market, respectively. Thanks to its high product quality, Shanxi Xintianyuan attracted the attention of Pfizer. Since last September, Pfizer has sent two groups of technical teams to conduct rigorous inspection of the firm and was satisfied with Shanxi Xintianyuan's technical standards as well as its soft and hard ware. (Click here for more - Chinese language)